Hot Pursuit     16-Jun-23
Zydus Lifesciences Ltd spurts 0.94%, up for five straight sessions
Zydus Lifesciences Ltd is quoting at Rs 554.3, up 0.94% on the day as on 12:44 IST on the NSE. The stock is up 65.12% in last one year as compared to a 22.6% gain in NIFTY and a 12.1% gain in the Nifty Metal.

Zydus Lifesciences Ltd is up for a fifth straight session in a row. The stock is quoting at Rs 554.3, up 0.94% on the day as on 12:44 IST on the NSE. The benchmark NIFTY is up around 0.33% on the day, quoting at 18750.45. The Sensex is at 63120.27, up 0.32%. Zydus Lifesciences Ltd has added around 6.84% in last one month.

Meanwhile, Nifty Metal index of which Zydus Lifesciences Ltd is a constituent, has added around 6.72% in last one month and is currently quoting at 13160.6, up 0.54% on the day. The volume in the stock stood at 10.31 lakh shares today, compared to the daily average of 12.97 lakh shares in last one month.

The benchmark June futures contract for the stock is quoting at Rs 553.95, up 0.58% on the day. Zydus Lifesciences Ltd is up 65.12% in last one year as compared to a 22.6% gain in NIFTY and a 12.1% gain in the Nifty Metal index.

The PE of the stock is 33.04 based on TTM earnings ending March 23.

Previous News
  Zydus Lifesciences consolidated net profit rises 30.64% in the June 2024 quarter
 ( Results - Announcements 09-Aug-24   13:48 )
  Zydus Lifesciences launches oncology drug - Rexigo™
 ( Corporate News - 30-Jan-24   09:49 )
  Zydus and Dr Reddy's ink licensing agreement to co-market Pertuzumab in India
 ( Corporate News - 28-Jun-24   19:04 )
  Zydus Life arm inks pact to acquire 50% stake in Sterling Biotech
 ( Hot Pursuit - 24-Aug-24   13:52 )
  Zydus Life gains on USFDA nod for prostatic hyperplasia drug
 ( Hot Pursuit - 18-Mar-24   09:40 )
  Zydus Life, Torrent Pharma to co-market chronic liver diseases treatment drug in India
 ( Hot Pursuit - 10-Nov-23   15:52 )
  Zydus Lifesciences Ltd gains for third straight session
 ( Hot Pursuit - 02-Jan-24   13:05 )
  Zydus receives USFDA final approval for Cyclophosphamide Capsules
 ( Corporate News - 14-Dec-23   18:57 )
  Zydus Life inks exclusive licensing & supply agreement for Palbociclib Tablets with Synthon
 ( Hot Pursuit - 19-Jan-24   09:46 )
  Torrent Pharmaceuticals and Zydus enter in licensing agreement for co-marketing Saroglitazar Magnesium
 ( Corporate News - 10-Nov-23   16:04 )
  Zydus' transdermal manufacturing site completes USFDA inspection
 ( Corporate News - 19-Jul-24   19:26 )
Other Stories
  IndusInd Bank Ltd down for fifth straight session
  07-Oct-24   13:35
  Canara Bank eases for fifth straight session
  07-Oct-24   13:35
  Eicher Motors Ltd slips for fifth straight session
  07-Oct-24   13:35
  Bajaj Auto Ltd eases for fifth straight session
  07-Oct-24   13:35
  Samvardhana Motherson International Ltd slips for fifth straight session
  07-Oct-24   13:35
  Maruti Suzuki India Ltd eases for fifth straight session
  07-Oct-24   13:35
  TVS Motor Company Ltd drops for fifth straight session
  07-Oct-24   13:35
  Reliance Industries Ltd drops for fifth straight session
  07-Oct-24   13:35
  Coal India Ltd eases for fifth straight session
  07-Oct-24   13:35
  Tata Power Company Ltd down for fifth straight session
  07-Oct-24   13:35
Back Top